-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Rhythm Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- Rhythm Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$43.6M, a 1.18% increase year-over-year.
- Rhythm Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$259M, a 39.5% decline year-over-year.
- Rhythm Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$185M, a 1.97% decline from 2022.
- Rhythm Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$181M, a 160% decline from 2021.
- Rhythm Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$69.6M, a 48% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)